Sophie Hordijk on A New Cause of the Hereditary Bleeding Disorder of VWD Type 1
Zeldzame bloedstollingsstoornissen shared on LinkedIn:
”New insights into Von Willebrand disease thanks to research
The latest issue of the Dutch Journal of Hematology features an interview with Sophie Hordijk, PhD candidate at the Department of Hematology at Erasmus MC in Ruben Bierings’ research group.
Sophie recently published a study in the leading journal Blood, in which she and her colleagues identified a new cause of the hereditary bleeding disorder Von Willebrand disease type 1.
The study points to impaired secretion of Von Willebrand Factor by endothelial cells as a possible key to a better understanding of the condition.
Curious about the scientific article?
Read it here.
Want to know more about Sophie Hordijk, Ruben Bierings, and the NTvH journal?
Take a look on LinkedIn:
- Sophie Hordijk
- Ruben Bierings
- Nederlands Tijdschrift voor Hematologie (Dutch Journal of Hematology)
Read the full interview here.”
Read the full article in Blood.
Article: A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants
Authors: Sophie Hordijk, Stijn A. Groten, Petra E. Bürgisser, Sebastiaan N. J. Laan, Georg Christoph Korenke, Tomáš Honzík, Diane Beysen, Frank W. G. Leebeek, Paul A. Skehel, Maartje van den Biggelaar, Tom Carter, Ruben Bierings

Stay updated on all scientific advances with Hemostasis Today.
-
Feb 19, 2026, 16:01Honoring Black Pioneers in Hematology During Black History Month – ASH
-
Feb 19, 2026, 15:16Irina Pahlevanyan: Global Leaders on Courage, Trust, and the True Purpose of Fundraising
-
Feb 19, 2026, 15:12Stéphanie Forté: Transition Readiness in Youth With Sickle Cell Disease
-
Feb 19, 2026, 15:08Tagreed Alkaltham: Strengthening Blood Inventory Governance Through RFID Technology
-
Feb 19, 2026, 14:59Başak Taburoğlu Yılmaz: Improving Diagnosis and Care for Women With Bleeding Disorders
-
Feb 19, 2026, 14:59Munira Borhany: Moving Beyond Stereotypes in the Diagnosis of Bleeding Disorders
-
Feb 19, 2026, 14:56Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
-
Feb 19, 2026, 14:54Michela Mazzon: The Molecular Trigger Behind the COVID19 Vaccines-Associated ITT
-
Feb 19, 2026, 14:42Luca Palombi: Real-Time Assessment of Venous Hemodynamics During Movement With DUS